Comparable risk of herpes simplex virus infection between topical treatments with tacrolimus and corticosteroids in adults with atopic dermatitis.
Hashizume
H
H
Yagi
H
H
Ohshima
A
A
Ito
T
T
Horibe
N
N
Yoshinari
Y
Y
Takigawa
M
M
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000328:Adult; D000368:Aged; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000009:adverse effects; D005260:Female; D006561:Herpes Simplex / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000276:immunology*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects*
D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus